Concepedia

Ashish Juvekar

AJ

12

Publications

1.6K

Citations

11

H-Index

2008

Active since

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

Cornell University

St. John's University

Boston University

Ashish Juvekar is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

2008–2020

12

Publications

12

Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer

Ashish Juvekar, Laura N. Burga, Hai Hu et al. · Cancer Discovery · 2012 · 475 citations · Full text

Phosphoinositide 3-Kinase Regulates Glycolysis through Mobilization of Aldolase from the Actin Cytoskeleton

Hai Hu, Ashish Juvekar, Costas A. Lyssiotis et al. · Cell · 2016 · 383 citations · Full text

, , +14

Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer

Evan C. Lien, Costas A. Lyssiotis, Ashish Juvekar et al. · Nature Cell Biology · 2016 · 243 citations · Full text

, , +9

Bortezomib Induces Nuclear Translocation of IκBα Resulting in Gene-Specific Suppression of NF-κB–Dependent Transcription and Induction of Apoptosis in CTCL

Ashish Juvekar, Subrata Manna, Sitharam Ramaswami et al. · Molecular Cancer Research · 2011 · 96 citations · Full text

Phosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletion

Ashish Juvekar, Hai Hu, Sina Yadegarynia et al. · Proceedings of the National Academy of Sciences · 2016 · 92 citations · Full text

Rows per page

1–5 of 12